Viral diversity news
Dr. David Bussy, intensivist at the Department of Intensive Care Medicine at Croix-Rousse University Hospital, and Kylian Trepat, PhD candidate, contributed to the article “Case-based evidence links increased SARS-CoV-2 diversity to impaired IFN-I response in severe...
RESPIFERON
As part of the REVIDA Chair, an article highlighting the use of the Type-I Interferon response as a universal marker for respiratory viral infections was recently accepted by the eBioMedicine journal. Titled “Advancing Respiratory Virus Diagnostics: Integrating the...
Literature review
Kylian TREPAT, doctoral student at the UCBL/HCL/bioMérieux joint research laboratory, published “Exploring viral respiratory coinfections: Shedding light on pathogen interactions” in September 2024, in PLoS Pathogens. This review of the literature, in the “Pearls”...
